Roberto L.
- Country
- Italy
- Department
- Oncology for pediatrics
Research Overview
- Phase 2 Evaluation of Naxitamab and Sargramostim in High-Risk Neuroblastoma with Refractory or Incomplete Response in Bone/Bone Marrow
- Phase 1 Study of INBRX-109 with Irinotecan and Temozolomide in Advanced Solid Tumors, Including Sarcomas, Ewing Sarcoma, and Colorectal Adenocarcinoma
- Phase I/II Multicenter Evaluation of Ribociclib with Topotecan and Temozolomide in Pediatric Patients with Relapsed or Refractory Neuroblastoma and Solid Tumors
Data & Insights
Has run more than one trial at 54 of 193 partner sites.
Specializations
Neuroblastoma Treatment
This investigator specializes in treating high-risk neuroblastoma, with particular focus on primary refractory disease and osteomedullary disease. Their research encompasses innovative approaches using antibody therapy combined with colony stimulating factors.
- Primary refractory neuroblastoma
- Bone and bone marrow involvement
- Immunotherapy approaches
Additional expertise includes treating relapsed neuroblastoma using combination therapeutic strategies.
Sarcoma Research
The investigator conducts research in Ewing sarcoma treatment, particularly focusing on refractory cases and multimetastatic disease. Their work includes evaluation of novel therapeutic combinations and conventional chemotherapy approaches.
- Primary refractory Ewing sarcoma
- Metastatic disease management
- Systemic therapy optimization
Research extends to investigating new therapeutic strategies for patients with advanced disease states.
Pediatric Solid Tumors
The investigator's expertise encompasses various pediatric solid tumors, including research on medulloblastoma, high-grade glioma, and rhabdomyosarcoma. Their work involves developing combination treatment approaches.
- Refractory solid tumors
- Novel drug combinations
- Treatment optimization strategies
Focus includes evaluation of targeted therapies in combination with conventional treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.